Department of Radiation Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan.
FASEB J. 2013 Jun;27(6):2316-27. doi: 10.1096/fj.12-226639. Epub 2013 Feb 26.
Hepatitis B virus (HBV) is implicated in liver cancer. The aim of this study was to find out whether HBV or its components [HBV surface antigen (HBsAg), HBV core protein (HBc), and HBV X protein (HBx)] could interfere with the host DNA damage response and repair pathway. The full HBV genome or individual HBV open-reading frame (ORF) was introduced into HepG2 cells to examine the effect on host genomic stability, DNA repair efficacy in response to double-strand DNA damage, and DNA damage-induced cell death. Responses to apoptosis induction in the HBV ORF-transfected HepG2 cells were also compared with those in HBV-positive and HBV-negative human hepatocellular carcinoma (HCC) cells. In the absence of HBV replication, accumulation of HBsAg in liver cells without other HBV proteins enhanced DNA repair protein and tumor suppressor promyelocytic leukemia (PML) degradation, which resulted in resistance to apoptosis induction and deficient double-strand DNA repair. However, HBsAg-positive cells exhibited increased cell death with exposure to the poly(ADP-ribose) polymerase inhibitor that blocks single-strand DNA repair. These results indicate that suppression of PML by HBsAg disrupts cellular mechanisms that respond to double-strand DNA damage for DNA repair or apoptosis induction, which may facilitate hepatocarcinogenesis and open up a synthetic lethality strategy for HBsAg-positive HCC treatment.
乙型肝炎病毒(HBV)与肝癌有关。本研究旨在探讨 HBV 或其成分(HBV 表面抗原 [HBsAg]、HBV 核心蛋白 [HBc]和 HBV X 蛋白 [HBx])是否会干扰宿主的 DNA 损伤反应和修复途径。将完整的 HBV 基因组或单个 HBV 开放阅读框(ORF)引入 HepG2 细胞,以检查对宿主基因组稳定性、双链 DNA 损伤后 DNA 修复效率以及 DNA 损伤诱导的细胞死亡的影响。还比较了 HBV ORF 转染 HepG2 细胞对细胞凋亡诱导的反应与 HBV 阳性和 HBV 阴性人肝癌(HCC)细胞的反应。在没有 HBV 复制的情况下,肝细胞中 HBsAg 的积累而没有其他 HBV 蛋白会增强 DNA 修复蛋白和肿瘤抑制因子早幼粒细胞白血病(PML)的降解,导致对细胞凋亡诱导和双链 DNA 修复的抵抗。然而,暴露于多聚(ADP-核糖)聚合酶抑制剂(该抑制剂阻断单链 DNA 修复)可使 HBsAg 阳性细胞的细胞死亡增加。这些结果表明,HBsAg 对 PML 的抑制破坏了细胞对双链 DNA 损伤进行 DNA 修复或细胞凋亡诱导的反应机制,这可能促进肝癌发生,并为 HBsAg 阳性 HCC 的治疗开辟了合成致死性策略。